OSLO, Norway, July 23, 2026 /PRNewswire/ -- Public trust in health innovation may be less predictable than healthcare organizations assume, according to new research from DNV, the independent assurance and certification provider.

A global survey of 12,500 people across 17 countries found that mindset is a stronger indicator of trust than traditional demographic factors such as age, income or geography.

The findings, published in DNV's new report The Future of Health: Four mindsets shaping trust, innovation and care challenge conventional approaches to audience segmentation and identify four distinct trust mindsets that influence how people evaluate healthcare, innovation and the future of care.

With health ecosystems facing growing pressure from ageing populations, workforce shortages and rapidly advancing technologies, understanding what builds public confidence will become critical.

Contrary to popular belief, the report finds that trust cannot be explained through demographics alone. People with similar demographic profiles can hold very different attitudes towards innovation and the future of health. The report identified four distinct mindsets of people building trust in healthcare: Trusting Optimists, Human Connectors, Evidence Evaluators and Pragmatic Realists.  

While Trusting Optimists are inclined to embrace new technologies that promise better outcomes and access to care, Human Connectors judge innovation through the lens of personal relationships and compassionate care. Evidence Evaluators look for transparency, accountability and proof that innovations deliver on their promises. The largest group identified in the research was Pragmatic Realists, people who judge innovation less by how advanced it is and more by whether it improves access, affordability and healthcare outcomes.

What makes these mindsets particularly significant is that they cut across traditional demographic boundaries. While age, income, health status and location all influence attitudes towards healthcare, they do not fully explain how people build trust. The research found, people with similar demographic profiles often belong to different trust mindsets, while people from very different backgrounds frequently share similar views on innovation and the future of care.

The findings also challenge common assumptions about age and technology. While older people are often viewed as more resistant to innovation and younger generations as more naturally accepting, the research suggests attitudes are shaped less by age than by people's experience of healthcare.

Across all four mindsets, one finding stood out. Nearly two-thirds of respondents, expressed concern that healthcare could become less personal as technology adoption accelerates, highlighting a shared expectation that innovation should strengthen and not replace the human experience of care.

The research suggests that people do not embrace innovation simply because it is new. Rather, confidence grows when technology is developed responsibly, assessed rigorously and implemented with patient outcomes in mind.

"Healthcare has never been innovating faster. But innovation alone won't determine the future of healthcare, trust will. Many assume trust is determined by age, gender or social status. Our research shows it's far more nuanced than that. Demographics influence trust, but do not define it." said Geir Fuglerud, CEO - Life Sciences at DNV. "The four mindsets we identify show that people build confidence in different ways, yet they share one important expectation: Technology should strengthen healthcare, not replace human care." 

The report The Future of Health: Four mindsets shaping trust, innovation and care is available to download here.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/public-trust-in-health-innovation-is-shaped-more-by-mindset-than-demographics-dnv-research-finds-302833319.html

Apotheken in Deutschland erhalten deutlich mehr Handlungsspielraum: Der Bundesrat hat eine Reform der schwarz-roten Koalition passieren lassen, die die Rolle der Offizinen im Gesundheitswesen spürbar aufwertet. Ziel ist es, die wohnortnahe Versorgung zu stärken, Wartezeiten in Arztpraxen zu reduzieren und Prävention sowie Früherkennung auszubauen. Das Paket war zuvor bereits vom Bundestag beschlossen worden.

Kern der Reform ist ein erweitertes Leistungsangebot in Apotheken. Künftig sollen dort zusätzliche Vorsorge- und Früherkennungsuntersuchungen möglich sein, etwa zu Herz-Kreislauf-Erkrankungen, Diabetes oder Angeboten rund um das Rauchen. Apotheken können damit stärker als bisher in der Prävention ansetzen und Risiken identifizieren, bevor es zu manifesten Erkrankungen kommt.

Auch im Impfbereich werden die Kompetenzen ausgeweitet. Neben den bereits etablierten Grippe- und Corona-Impfungen dürfen Apotheken künftig alle Schutzimpfungen mit sogenannten Totimpfstoffen anbieten, darunter etwa Tetanus. Ergänzend werden Blutabnahmen erlaubt, etwa um Medikamentenwirkungen zu kontrollieren. Damit rücken Apotheken näher an klassische ärztliche Tätigkeitsfelder heran, ohne diese vollständig zu ersetzen.

Besonders sensibel ist die neue Möglichkeit, in eng begrenzten Fällen verschreibungspflichtige Medikamente ohne ärztliche Verordnung abzugeben. Erlaubt ist künftig die einmalige Ausgabe der kleinsten Packungsgröße auf Selbstzahlerbasis, wenn ein Arzneimittel seit längerem eingenommen wird und die Fortführung der Therapie keinen Aufschub erlaubt. Die Regelung soll Versorgungslücken schließen, etwa wenn ein Rezept nicht rechtzeitig vorliegt, und bleibt zugleich strikt begrenzt, um Missbrauch zu vermeiden.